19-7637185-A-G
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP7
The NM_006949.4(STXBP2):āc.36A>Gā(p.Glu12=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,243,358 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_006949.4 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
STXBP2 | NM_006949.4 | c.36A>G | p.Glu12= | splice_region_variant, synonymous_variant | 1/19 | ENST00000221283.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
STXBP2 | ENST00000221283.10 | c.36A>G | p.Glu12= | splice_region_variant, synonymous_variant | 1/19 | 1 | NM_006949.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000884 AC: 1AN: 11318Hom.: 0 AF XY: 0.000184 AC XY: 1AN XY: 5448
GnomAD4 exome AF: 0.0000202 AC: 22AN: 1091278Hom.: 0 Cov.: 31 AF XY: 0.0000175 AC XY: 9AN XY: 515606
GnomAD4 genome AF: 0.000118 AC: 18AN: 152080Hom.: 0 Cov.: 33 AF XY: 0.0000808 AC XY: 6AN XY: 74264
ClinVar
Submissions by phenotype
STXBP2-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 24, 2023 | The STXBP2 c.36A>G variant is not predicted to result in an amino acid change (p.=). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.042% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-7702071-A-G). Available splicing prediction programs indicate that this variant may reduce the strength of the neighboring donor splice site and affect splicing (-23.7%; Alamut Visual Plus v.1.6.1). However, such computer prediction programs are imperfect. This variant is reported as variant of unknown significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/1036793/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Familial hemophagocytic lymphohistiocytosis 5 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | This sequence change affects codon 12 of the STXBP2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the STXBP2 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs765466426, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with STXBP2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1036793). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at